| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Profit Covers Many Sins - Ten Principles for Success in 2007 |
|
Just Other Articles - Profit Covers Many Sins - Ten Principles for Success in 2007
Profit Covers Many Sins - Ten principles that can help us maintain our focus, uncover some of those sins that may have been covered by profitability in 2006 and cr According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product eate the kind of success in 2007 that you can be proud of: 1. Go back to basics in managing your business. ----- Take the time to review best practices as they app ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in y to your business. Look at your processes, your procedures and your policies 2. Understand your role in the market place. ----- Do an internal SWOT analysis (Str lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. engths, Weaknesses, Opportunities & Threats) with your management team and initiate a brainstorming or scenario planning session to reflect upon your changing role here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe s a distributor in 2007 and beyond. 3. Develop or refine your strategic plans. --- If you don’t have a strategic plan, make it a priority to create one in 2007. It d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro is money well spent. If you do have one, go through an extensive review of all the initiatives. 4. Create branch and operational plans that are alignment with your ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc strategies. --- If you have multiple branches insist upon a branch planning process that goes beyond turning in a budget. Make sure the plan is documented with tim easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi lines and accountability. 5. Continue to develop and train employees (Don’t scrimp here). --- Continue to focus on people development. This will maintain employee nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically respect, trust and will create a culture that will maximize employee efforts and willingness to do whatever it takes to create success. 6. Upgrade your sales force and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ and all support services. --- While employee development is critical to success, so is making sure that you have the right employees performing the right functions. ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi Don’t let too much compassion for long tenure employees cloud your judgment. 7. Manage your inventory. --- Inventory for the vast majority of distributors is gener ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ally the largest asset on the balance sheet and the easiest one to lose control of. Sales people like to say you can’t sell from an empty wagon but we all must real dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ze that market forces will dictate what inventory levels are appropriate for individual success. 8. Understand and manage your cash to cash cycle. --- Inventory is cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin certainly part of the cash to cash cycle but managing your payables and your receivables is also extremely important to cash flow. Profits are not necessarily cash tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen so paying attention to cash flow is a very basic principle of success. 9. Insist upon sales territory plans that target accounts based on potential for growth. --- t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel It’s really fun being a sales person in an “Easy Profit” market. It is not difficult to do well and sometimes we can be lulled into a sense of eternal success that ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust doesn’t require a 100% effort. It can lead to a comfort zone that is not healthy for long term success. Make sure your sales force practices a sales effectiveness d y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products scipline that requires documented action planning for specific targeted accounts that support individual territory plans. 10. Create change based on changes in yo . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ur markets and your industry. --- Creating, instigating and managing change takes passion and courage. It’s not for the weak of heart. It is not for those who embr elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ce simple traditional expectations. Effective leaders reach beyond these expectations. They become agents of change. Change is imperative in a “Tough Profit” market tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Attention: Entrepreneurs -- Is Your Business Name Working? How To Start Your Own Import Business
|